Preventive Care and Immunizations

105 questions

Question 41Question →

Select the newly indicated universal screening test that corresponds to each pediatric patient attending their scheduled health maintenance visit according to current guidelines.

Click a left item, then click its matching right item

Items

A 12-month-old infant presenting for a routine health maintenance examination
An 18-month-old toddler presenting for a routine health maintenance examination
A 10-year-old child presenting for an annual physical examination
A 12-year-old adolescent presenting for a sports preparticipation evaluation

Matches

Show answer & explanation

Answer

The 12-month-old requires anemia screening; the 18-month-old requires autism screening; the 10-year-old requires dyslipidemia screening; and the 12-year-old requires depression screening.
Each specific screening intervention must be matched with its corresponding initiation age as mandated by routine pediatric health maintenance guidelines (e.g., AAP Bright Futures). Anemia is universally screened at 12 months, autism explicitly at 18 and 24 months, lipid profiles universally between 9-11 years, and depression annually starting at 12 years.

Step-by-Step Solution

1
Determine the unique screening requirement introduced at the 12-month milestone.
Anemia screening via hemoglobin or hematocrit is identified as universally required at 1 year of age.
This detects nutritional iron deficiency common during the transition to whole cow's milk.
2
Determine the specific developmental screening initiated at the 18-month visit.
Autism spectrum disorder screening is required.
Early detection of autism signs at 18 and 24 months significantly improves long-term neurodevelopmental outcomes through early intervention.
3
Identify the cardiovascular screening recommended for school-aged children.
Universal dyslipidemia screening is identified for the 9 to 11-year age bracket.
Early identification of familial hypercholesterolemia and other lipid disorders prevents premature cardiovascular disease.
4
Identify the behavioral health screening introduced at the onset of adolescence (12 years).
Major depressive disorder screening is selected.
Adolescence marks a significant increase in the incidence of depression, warranting routine annual screening starting at age 12.

Key Concept

Age-specific universal screening guidelines in pediatric preventive care.
Question 42Question →

A pediatric clinic is reviewing its protocols for vaccine safety and administration. Match each pediatric patient's clinical history to the corresponding vaccine contraindication or appropriate management step.

Click a left item, then click its matching right item

Items

A 2-month-old infant with a past medical history of intussusception
A 4-month-old infant who developed unexplained encephalopathy 3 days after receiving their 2-month immunizations
A 12-month-old child recently diagnosed with severe combined immunodeficiency (SCID)
A 6-month-old infant who experiences isolated hives after eating eggs

Matches

Show answer & explanation

Answer

The infant with intussusception matches with the rotavirus vaccine contraindication; the infant with encephalopathy matches with the pertussis vaccine contraindication; the child with SCID matches with the live-attenuated vaccine contraindication; and the infant with an egg allergy matches with no contraindication.
Each clinical presentation aligns with a specific immunization rule. Intussusception history strictly contraindicates rotavirus vaccination. Unexplained encephalopathy within 7 days of a DTaP dose strictly contraindicates further pertussis vaccination. Severe cellular immunodeficiency (SCID) strictly contraindicates all live-attenuated vaccines (like MMR and Varicella). Conversely, egg allergy is a false contraindication; the influenza vaccine can and should be administered safely.

Step-by-Step Solution

1
Evaluate the patient with a history of intussusception
Identify that rotavirus vaccine is contraindicated
The rotavirus vaccine specifically increases the risk of intussusception, making prior episodes an absolute contraindication.
2
Evaluate the patient who developed encephalopathy after prior immunizations
Identify that pertussis-containing vaccines (DTaP) are contraindicated
Encephalopathy within 7 days of administration is an absolute contraindication specifically for the pertussis component of the DTaP vaccine.
3
Evaluate the patient with severe combined immunodeficiency (SCID)
Identify that live-attenuated vaccines are contraindicated
Patients with severe cellular immunodeficiency cannot mount a proper immune response and are at high risk of developing severe systemic infections from live vaccine strains.
4
Evaluate the patient with an egg allergy
Identify that there is no contraindication for routine vaccines
Current guidelines state that egg allergy of any severity is not a contraindication to the influenza vaccine (or any other routine childhood vaccine), and it can be safely given in routine settings.

Key Concept

True versus false absolute contraindications for routine childhood immunizations.
Question 43Question →

During a pre-scheduled visit for health maintenance, a physician evaluates a 1-year-old male infant. Medical history is notable for severe atopic dermatitis, which recently necessitated a prolonged course of systemic corticosteroids. Specifically, he has been taking oral prednisone (2 mg/kg daily) for the past 28 days. His skin flare has now largely resolved, and the physician plans a gradual taper of the medication. The infant is clinically stable, afebrile, and behaving normally. According to his medical records, he received all indicated immunizations during his first 6 months of life. As the physician prepares orders for today's routine immunizations, which of the following preparations is strictly contraindicated at this time?

Show answer & explanation

Answer: Measles-mumps-rubella vaccine

Answer

The measles-mumps-rubella (MMR) vaccine is strictly contraindicated because it is a live-attenuated vaccine and the patient is currently severely immunocompromised from high-dose corticosteroid therapy.
The correct answer is the measles-mumps-rubella (MMR) vaccine. Patients receiving high-dose systemic corticosteroids, defined as greater than or equal to 2 mg/kg/day (or 20 mg/day) of prednisone for 14 days or longer, are considered severely immunocompromised. In such patients, all live-attenuated vaccines, including the MMR and varicella vaccines, are strictly contraindicated due to the severe risk of uncontrolled vaccine-strain viral replication and disseminated infection. High-dose systemic steroids must be discontinued for at least 1 month before live vaccines can be safely administered.

Step-by-Step Solution

1
Identify the patient's current medication status and dosage.
The patient has been taking 2 mg/kg/day of oral prednisone for 28 days.
Corticosteroid dosage and duration determine the degree of pharmacologic immunosuppression.
2
Determine if the medication regimen meets the criteria for severe immunosuppression.
Yes. A dose of 2 mg/kg/day (or 20 mg/day) of prednisone for 14 or more consecutive days constitutes severe immunosuppression.
This specific threshold is used by the CDC to determine when live vaccines can be safely administered to pediatric patients.
3
Classify the routine 12-month vaccine options into live-attenuated versus inactivated categories.
The MMR vaccine is live-attenuated, while Hib, Hepatitis A, Hepatitis B, and Pneumococcal conjugate vaccines are inactivated or subunit formulations.
Live-attenuated vaccines are contraindicated during severe immunosuppression due to the risk of uncontrolled vaccine-strain viral replication, whereas inactivated vaccines are safe to administer.

Key Concept

Patients receiving high-dose systemic corticosteroids (≥2 mg/kg/day or ≥20 mg/day of prednisone for ≥14 days) are considered severely immunocompromised and should not receive live-attenuated vaccines such as MMR and varicella until therapy is discontinued for at least 1 month.
Question 44Question →

A 15-month-old boy is brought to the clinic for a routine well-child visit. His family recently relocated to the area, and he has not received any immunizations since his 6-month visit. His mother is currently 22 weeks pregnant. During the evaluation, the parents express concern that the boy is developmentally delayed because he does not yet speak in two-word phrases or run. They also state they want to avoid any "live virus" vaccines today, as they read online that these could pose a risk to the mother's pregnancy. Physical examination is unremarkable. The boy can walk independently, stack two blocks, scribble spontaneously with a crayon, and clearly say "cup," "ball," and "dog" in addition to "mama" and "dada." Which of the following is the most appropriate action regarding this patient's care?

Show answer & explanation

Answer: Reassure the parents regarding his development and administer all age-appropriate vaccines

Answer

The most appropriate action is to reassure the parents regarding his development and administer all age-appropriate vaccines, including live-attenuated vaccines.
This patient is exhibiting normal developmental milestones for a 15-month-old child, and healthy children living with pregnant women should receive all scheduled immunizations, including live-attenuated vaccines. At 15 months, normal milestones include walking independently (gross motor), building a 2-block tower and scribbling (fine motor), knowing 3 to 5 words beyond "mama" and "dada" (language), and following one-step commands (social/cognitive). The parents' expectations of running and using two-word phrases represent milestones for 18 months and 24 months, respectively. Therefore, reassurance rather than referral is appropriate. Furthermore, while live-attenuated vaccines are absolutely contraindicated in pregnant women themselves, they are safely and routinely administered to their immunocompetent pediatric contacts. The measles, mumps, and rubella (MMR) vaccine viruses do not transmit to contacts. While the varicella vaccine virus can rarely transmit if the vaccinated child develops a vesicular rash, standard guidelines still mandate its administration, as the benefits of creating household immunity to protect the pregnant woman from wild-type infection far outweigh this theoretical risk.

Step-by-Step Solution

1
Assess the patient's developmental milestones for his age (15 months).
The patient's abilities to walk independently, stack two blocks, scribble, and say 3 words besides mama/dada align perfectly with normal 15-month milestones.
To determine if the parents' concerns about delayed speech and motor skills warrant a referral.
2
Evaluate the parental concern regarding the timeline for two-word phrases and running.
Speaking in two-word phrases is a 24-month milestone, and running is an 18-month milestone.
To confirm that the child is not developmentally delayed, meaning reassurance (rather than a referral) is the correct management.
3
Determine if the mother's pregnancy is a contraindication to administering live-attenuated vaccines (MMR, Varicella) to the child.
Pregnancy in a household contact is NOT a contraindication to routine vaccination of immunocompetent children with MMR and varicella vaccines.
To decide whether to proceed with the full catch-up immunization schedule for this child who missed his 12-month visit.

Key Concept

Normal developmental milestones at 15 months and the safety of live-attenuated vaccines in healthy children with pregnant household contacts.
Question 45Question →

A pediatric health system is updating its electronic medical record (EMR) alerts to automatically prompt clinicians for age-appropriate universal screening tests during routine well-child visits. Arrange the following universal screening interventions in chronological order based on the earliest age they are routinely recommended for a healthy, asymptomatic pediatric patient, starting from birth.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with Critical Congenital Heart Disease (newborn), followed by Autism Spectrum Disorder (18 months), Dyslipidemia (9-11 years), Major Depressive Disorder (12 years), and finally HIV (15-18 years).
The American Academy of Pediatrics (AAP) Bright Futures periodicity schedule mandates universal screenings at specific intervals. Critical congenital heart disease (CCHD) screening via pulse oximetry is performed in the newborn period (24-48 hours). Autism spectrum disorder (ASD) screening is conducted at 18 and 24 months of age. Universal dyslipidemia screening is recommended once between 9 and 11 years to identify early familial hypercholesterolemia before pubertal lipid shifts. Major depressive disorder (MDD) screening is initiated universally at age 12 and continued annually. Finally, routine, universal HIV screening is recommended at least once between the ages of 15 and 18 years, regardless of sexual activity.

Step-by-Step Solution

1
Identify the screening test recommended immediately after birth.
Critical congenital heart disease (CCHD) screening.
CCHD screening using pulse oximetry is a standard newborn screening test performed at 24 to 48 hours of life before hospital discharge.
2
Identify the early childhood screening milestone.
Autism spectrum disorder (ASD) screening.
While general developmental screening occurs at 9, 15, and 30 months, autism-specific universal screening using tools like the M-CHAT is strictly recommended at 18 and 24 months.
3
Determine the screening test scheduled for late childhood/pre-adolescence.
Dyslipidemia screening.
Universal screening for dyslipidemia (regardless of family history) is recommended to be performed once between ages 9 and 11 years.
4
Sequence the adolescent screening tests based on starting age.
Major depressive disorder (MDD) screening before HIV screening.
MDD screening begins at age 12 and occurs annually. HIV screening is universally recommended at least once for all youth between ages 15 and 18, placing its initial universal recommendation slightly later in the chronological sequence.

Key Concept

The American Academy of Pediatrics (AAP) Bright Futures periodicity schedule dictates specific ages for universal preventive screenings to detect asymptomatic conditions early.
Question 46Question →

A pediatric clinic is reviewing the immunization records of several patients with specific underlying conditions or clinical circumstances. Match each pediatric patient with the specific vaccine or immunoprophylaxis that is most appropriately indicated for their ongoing care.

Click a left item, then click its matching right item

Items

A 16-year-old adolescent boy with a newly diagnosed terminal complement pathway deficiency
A 15-year-old adolescent girl who is currently at 28 weeks of gestation
A 3-year-old boy scheduled to undergo cochlear implant surgery next month
A 6-month-old infant boy born at 26 weeks gestation with bronchopulmonary dysplasia, presenting for a visit in late October

Matches

Show answer & explanation

Answer

The correct matches align specific high-risk pediatric conditions with their targeted immunizations: complement deficiency pairs with MenB, pregnancy pairs with Tdap, cochlear implants pair with PPSV23, and premature infants with lung disease pair with RSV immunoprophylaxis.
Each patient in the stem presents with a specific risk factor that directly alters their routine immunization requirements. Terminal complement deficiency requires MenB to prevent lethal meningococcal disease. Pregnancy necessitates Tdap in the third trimester for neonatal pertussis protection. Cochlear implants place children at high risk for pneumococcal meningitis, requiring PPSV23 in addition to standard conjugate vaccines. Premature infants with chronic lung disease require RSV immunoprophylaxis entering their first RSV season.

Step-by-Step Solution

1
Evaluate the immunization needs of the 16-year-old with terminal complement deficiency.
Matches with Meningococcal B (MenB) vaccine.
Terminal complement deficiency impairs the body's ability to lyse encapsulated bacteria, specifically creating a severe vulnerability to Neisseria meningitidis, necessitating complete meningococcal vaccination (MenACWY and MenB).
2
Evaluate the immunization needs of the pregnant 15-year-old at 28 weeks gestation.
Matches with Tdap vaccine.
Standard prenatal care guidelines require Tdap administration between 27-36 weeks in every pregnancy to ensure protective maternal antibodies are transferred to the infant against pertussis.
3
Evaluate the immunization needs of the 3-year-old needing a cochlear implant.
Matches with 23-valent pneumococcal polysaccharide vaccine (PPSV23).
Cochlear implants provide a potential anatomical pathway for bacteria to enter the central nervous system, heightening the risk for pneumococcal meningitis. PPSV23 expands serotype coverage for high-risk children over age 2.
4
Evaluate the immunization needs of the premature 6-month-old with bronchopulmonary dysplasia entering autumn.
Matches with RSV immunoprophylaxis.
Premature infants with chronic lung disease lack adequate airway reserves and maternal antibody transfer, requiring passive immunization against RSV during the peak transmission season.

Key Concept

Special immunization indications for pediatric patients with high-risk underlying conditions
Question 47Question →

A 12-month-old boy is brought to the office for a routine well-child visit. Three months ago, he was hospitalized for a 5-day history of high fever, polymorphic rash, bilateral conjunctival injection, and cervical lymphadenopathy. He was diagnosed with Kawasaki disease and treated successfully with high-dose intravenous immunoglobulin (IVIG) and aspirin. He is currently taking no medications. The mother expresses concern that her son is not yet walking independently and only says "mama" and "dada" specifically. He pulls to stand, cruises along furniture, uses a neat pincer grasp, and points to objects. His length, weight, and head circumference are at the 50th percentile. Physical examination is normal. His immunization record shows he received all recommended vaccines at ages 2, 4, and 6 months. Which of the following is the most appropriate management for this patient today?

Show answer & explanation

Answer: Administer Haemophilus influenzae type b, pneumococcal conjugate, and hepatitis A vaccines; defer MMR and varicella vaccines; reassure the mother

Answer

Administer inactivated vaccines (Haemophilus influenzae type b, pneumococcal conjugate, and hepatitis A), defer live vaccines (MMR and varicella), and reassure the mother regarding his normal development.
The correct approach involves administering age-appropriate inactivated vaccines (Haemophilus influenzae type b, pneumococcal conjugate, and hepatitis A), deferring live-attenuated vaccines (measles, mumps, and rubella [MMR] and varicella), and providing reassurance regarding the patient's normal development. High-dose intravenous immunoglobulin (IVIG), which this patient received for Kawasaki disease at age 9 months, contains pooled IgG antibodies. These antibodies can neutralize live-attenuated viruses, leading to a diminished immune response. Therefore, live vaccines must be deferred for up to 11 months after high-dose IVIG administration. However, IVIG does not interfere with the immune response to inactivated vaccines or toxoids, which should be administered on their regular schedule. Additionally, this patient's milestones (cruising, pincer grasp, specific 'mama'/'dada', and pointing) are entirely normal for a 12-month-old. Independent walking is generally achieved by 12 to 15 months, so the mother should be reassured without further developmental referral.

Step-by-Step Solution

1
Assess the patient's developmental milestones.
Cruising, pincer grasp, saying 'mama' and 'dada', and pointing are normal milestones for a 12-month-old.
To address the mother's concern and determine if early intervention is needed.
2
Evaluate the patient's immunization needs for the 12-month well-child visit.
Routine immunizations due at 12 months include Hib, PCV, HepA, MMR, and Varicella.
To provide routine preventive care based on the standard immunization schedule.
3
Determine the impact of the patient's recent medical history (Kawasaki disease treated with IVIG) on his vaccination schedule.
High-dose IVIG contains antibodies that interfere with live-attenuated vaccines. Therefore, MMR and varicella must be deferred for 11 months post-IVIG.
To ensure vaccine efficacy.

Key Concept

Administration of live-attenuated vaccines (like MMR and varicella) must be deferred for up to 11 months following high-dose IVIG therapy, but inactivated vaccines should be given on schedule. Independent walking is not expected until 12-15 months.
Question 48Question →

A 1-week-old male newborn is brought to the pediatric clinic for his initial newborn follow-up visit. He was born at 39 weeks gestation via an uncomplicated spontaneous vaginal delivery to a 28-year-old primigravida. His birth weight was 3.4 kg (7 lb 8 oz). Current vital signs include a temperature of 36.8°C (98.2°F), heart rate of 140/min, and respiratory rate of 40/min. Physical examination reveals a healthy, vigorous neonate with normal muscle tone, a flat anterior fontanelle, and symmetric primitive reflexes. He received the first dose of the hepatitis B vaccine at birth and is feeding well on demand. His first-time parents are eager to understand what to expect regarding his neurodevelopmental progress over the coming years.

Arrange the following developmental milestone clusters in the chronological order of their expected emergence in a typically developing healthy child.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 4 months (brings hands to midline, laughs), 9 months (pulls to stand, stranger anxiety), 18 months (runs, 4-block tower), 3 years (pedals tricycle, 3-word sentences), and 5 years (copies triangle, catches ball).
Normal pediatric development follows a predictable sequence that must be understood for effective health maintenance and anticipatory guidance. At 4 months, infants bring their hands to the midline and laugh. By 9 months, they pull to stand and demonstrate stranger anxiety. At 18 months, a toddler has progressed to running and can stack a tower of four blocks. A 3-year-old typically achieves the classic milestones of pedaling a tricycle and speaking in three-word sentences. Finally, a 5-year-old possesses the advanced fine motor control to copy a triangle and the coordination to catch a bounced ball.

Step-by-Step Solution

1
Determine the expected age for the cluster: 'Brings hands to the midline and laughs aloud.'
This corresponds to the 4-month well-child visit milestones.
By 4 months, infants develop the motor control to engage their hands at the midline and begin laughing spontaneously.
2
Determine the expected age for the cluster: 'Pulls to a standing position and exhibits stranger anxiety.'
This corresponds to the 9-month well-child visit milestones.
At 9 months, core strength allows for pulling to stand, and cognitive development triggers stranger anxiety.
3
Determine the expected age for the cluster: 'Runs independently and builds a tower of four blocks.'
This corresponds to the 18-month well-child visit milestones.
Independent running and the fine motor precision to stack 4 blocks (but not yet 6) consolidate around 18 months.
4
Determine the expected age for the cluster: 'Pedals a tricycle and speaks in three-word sentences.'
This corresponds to the 3-year (36 months) well-child visit milestones.
A 3-year-old characteristically achieves 'rules of 3': 3-word sentences, riding a tricycle (3 wheels), and copying a 1-line closed shape (circle).
5
Determine the expected age for the cluster: 'Copies a triangle and catches a bounced ball.'
This corresponds to the 5-year (60 months) well-child visit milestones.
Copying complex shapes with intersecting oblique lines (triangle) and catching a ball require mature 5-year-old coordination.
6
Arrange the identified ages in chronological order.
4 months, 9 months, 18 months, 36 months, 60 months.
This establishes the correct temporal sequence of typical developmental emergence.

Key Concept

Normal pediatric growth and development follow a predictable chronological sequence across gross motor, fine motor, language, and social domains, which is actively monitored during scheduled preventive care visits.
Estimated Time:1m 0s
Question 49Question →

A 5-year-old boy is brought to the clinic for a well-child examination prior to starting kindergarten. His medical history is notable for severe polyarticular juvenile idiopathic arthritis. For the past 6 months, his condition has been exceptionally well controlled on a regimen of subcutaneous etanercept and oral methotrexate. His mother states he has been entirely asymptomatic. A review of his immunization records shows that he received all required infant and toddler vaccinations up to age 2, but he has not yet received any of his standard preschool booster vaccines. The mother also expresses concern that her son cannot yet copy a diamond or independently tie his shoelaces. Observation in the clinic reveals he can skip, copy a triangle, and accurately count to 10. Vital signs and physical examination are normal. Which of the following is the most appropriate management plan for this patient today?

Show answer & explanation

Answer: Administer DTaP and IPV; reassure the mother regarding his development

Answer

Administer DTaP and IPV; reassure the mother regarding his development
The correct management plan involves administering the inactivated vaccines (DTaP and IPV) while deferring the live-attenuated vaccines (MMR and varicella). This 5-year-old patient is severely immunocompromised due to his treatment with etanercept (a biologic agent) and methotrexate. Live-attenuated vaccines pose a risk of uncontrolled replication and disseminated disease in such patients and are therefore strictly contraindicated. Conversely, inactivated vaccines are safe and should be given on schedule to provide protection, even though the total immune response may be blunted. Regarding development, his ability to skip, copy a triangle, and count to 10 confirms normal 5-year-old milestones. His inability to copy a diamond or tie his shoelaces is appropriate for his age, as these are typically mastered at age 6; therefore, reassurance is the correct action.

Step-by-Step Solution

1
Determine the required vaccines for a 5-year-old child.
The standard preschool boosters given between 4 and 6 years of age are DTaP, IPV, MMR, and varicella.
Identifying the baseline requirement is necessary before adjusting for the patient's specific medical conditions.
2
Evaluate the patient's immune status based on current medications.
The patient is taking etanercept (a TNF-alpha inhibitor) and methotrexate, which cause significant immunosuppression.
Immunosuppression status dictates the safety profile of different vaccine types.
3
Apply vaccine contraindication guidelines for immunocompromised patients.
Live-attenuated vaccines (MMR, varicella) are strictly contraindicated, but inactivated vaccines (DTaP, IPV) are safe and should be administered.
Live vaccines can cause disseminated, life-threatening infections in immunosuppressed hosts, whereas inactivated vaccines pose no such risk.
4
Assess the patient's developmental milestones against age expectations.
Skipping, copying a triangle, and counting to 10 are normal 5-year-old milestones. Tying shoelaces and copying a diamond are typical 6-year-old milestones.
Determining if the mother's concern is valid dictates whether reassurance or a specialist referral is appropriate.

Key Concept

Live-attenuated vaccines are contraindicated in severely immunocompromised patients, whereas inactivated vaccines remain indicated. Additionally, tying shoelaces and copying a diamond are typical 6-year-old milestones, not 5-year-old milestones.
Estimated Time:1m 30s
Question 50Question →

A 4-year-old boy is brought to the pediatric clinic in late September for a well-child visit. He was diagnosed with moderate-to-severe Crohn disease 6 months ago. His current medications include infliximab, a tumor necrosis factor-alpha (TNF-α) inhibitor, which has led to clinical remission and appropriate weight gain. He has no other medical conditions. His immunizations were up to date until his 18-month visit. He is now due for his routine preschool vaccinations, and the parents also request the seasonal influenza vaccine. His vital signs are temperature 36.8°C (98.2°F), heart rate 98/min, and respiratory rate 20/min. Physical examination is unremarkable.

Which of the following is the most appropriate immunization plan for this patient today?

Show answer & explanation

Answer: Administer DTaP, IPV, and inactivated influenza vaccines; defer MMR and varicella vaccines

Answer

The most appropriate plan is to administer the inactivated vaccines (DTaP, IPV, and inactivated influenza) and to defer the live-attenuated vaccines (MMR and varicella).
The correct plan involves administering only the inactivated vaccines (DTaP, IPV, and inactivated influenza) and deferring the live-attenuated vaccines (MMR and varicella). This patient is receiving infliximab, a TNF-α inhibitor, which is a potent immunosuppressant. In severely immunocompromised patients, live-attenuated vaccines are strictly contraindicated because the vaccine strain viruses can undergo uncontrolled replication, leading to severe and potentially fatal disseminated disease. Conversely, inactivated vaccines cannot cause infectious disease and are safe to administer to immunocompromised individuals. They should be given on schedule to provide necessary protection, even though the overall immune response might be slightly blunted.

Step-by-Step Solution

1
Evaluate the patient's immune status based on his current medications.
The patient is taking infliximab, a biologic TNF-α inhibitor, which causes significant systemic immunosuppression.
Determining the immune status is the critical first step before administering any vaccines, as it dictates vaccine safety.
2
Determine the safety profile of the indicated preschool vaccines (DTaP, IPV, MMR, varicella, and seasonal influenza) in an immunocompromised host.
DTaP, IPV, and standard seasonal influenza vaccines are inactivated and safe. MMR and varicella are live-attenuated vaccines and are contraindicated.
Live-attenuated vaccines can cause uncontrolled viral replication and severe disease in immunocompromised patients, whereas inactivated vaccines pose no infectious risk.
3
Formulate the appropriate immunization plan for today's visit.
The plan must include the administration of the safe inactivated vaccines (DTaP, IPV, influenza) and the deferral of the contraindicated live vaccines (MMR, varicella).
This strategy maximizes the patient's protection against vaccine-preventable diseases without exposing him to the dangers of live vaccine administration.

Key Concept

In severely immunocompromised pediatric patients, such as those on TNF-α inhibitors, live-attenuated vaccines (e.g., MMR, varicella) are strictly contraindicated due to the risk of disseminated infection, whereas inactivated vaccines (e.g., DTaP, IPV) are safe and should be administered according to the routine schedule.
Estimated Time:1m 30s
Question 51Question →

A 2-month-old girl is brought to the clinic for her first well-child examination. She was born at 39 weeks gestation via spontaneous vaginal delivery. Her mother has a history of severe, refractory Crohn's disease, which has been managed with regular infusions of infliximab throughout the pregnancy, with the final dose administered at 36 weeks gestation. The infant's newborn screen was normal. She has been exclusively breastfed and is gaining weight well. On examination, the infant appears well. She smiles responsively, makes cooing sounds, and tracks the examiner's face past the midline. When placed in the prone position, she is able to lift her head to 45 degrees. The mother expresses concern that the infant is not yet reaching for objects or rolling over. Her tone and reflexes are normal. She previously received the Hepatitis B vaccine at birth. Which of the following is the most appropriate next step in management regarding her immunizations and development?

Show answer & explanation

Answer: Reassure the mother regarding development; administer DTaP, Hib, PCV, IPV, and Hepatitis B vaccines; and withhold the rotavirus vaccine

Answer

The most appropriate management is to reassure the mother regarding the infant's normal development, administer all routine inactivated vaccines (DTaP, Hib, PCV, IPV, Hepatitis B), and withhold the live rotavirus vaccine.
The correct management is to reassure the mother regarding the infant's normal development, administer the routine inactivated vaccines, and withhold the live rotavirus vaccine. At 2 months of age, normal milestones include social smiling, cooing, tracking past the midline, and lifting the head to 45 degrees when prone. The mother's concerns regarding the lack of reaching for objects and rolling over are unfounded, as these are typically 4-month milestones; therefore, reassurance is appropriate rather than a developmental referral. Regarding immunizations, the routine 2-month schedule includes DTaP, Hib, PCV, IPV, Hepatitis B, and rotavirus. However, this infant was exposed to infliximab (a TNF-alpha inhibitor) in utero during the third trimester. Monoclonal IgG antibodies actively cross the placenta and can cause profound immunosuppression in the infant for up to 6 months after birth. Consequently, the administration of live-attenuated vaccines, such as the oral rotavirus vaccine, is strictly contraindicated during this period due to the risk of severe, disseminated vaccine-strain infection. In contrast, all inactivated vaccines are safe and should be administered according to the normal schedule.

Step-by-Step Solution

1
Assess the infant's developmental milestones.
The infant smiles, coos, tracks past the midline, and lifts her head 45 degrees when prone. The lack of reaching and rolling over is entirely normal at 2 months of age.
To address the mother's concerns and determine if a developmental referral is clinically warranted.
2
Determine the routine immunization requirements at 2 months of age.
The standard schedule includes DTaP, Hib, PCV, IPV, Hepatitis B, and rotavirus vaccines.
To establish the baseline recommended vaccines before considering maternal and patient history for contraindications.
3
Identify any contraindications based on the infant's in utero exposure.
The infant was exposed to infliximab (an IgG1 monoclonal antibody) in utero. These biologic agents actively cross the placenta and cause systemic immunosuppression in the infant that can persist for up to 6 months.
Maternal use of biologic immunosuppressants dictates the safety profile of live vaccines in the neonate.
4
Synthesize the findings to formulate the safest management plan.
Reassure the mother about development. Administer all inactivated vaccines, as they are safe. Withhold the live rotavirus vaccine to prevent disseminated vaccine-strain infection.
To provide necessary preventive care while avoiding life-threatening complications in an immunocompromised host.

Key Concept

Infants exposed to biological immunomodulators (e.g., infliximab, adalimumab) in utero during the second or third trimester should not receive live-attenuated vaccines (like rotavirus) for the first 6 months of life, though all inactivated vaccines should be administered on the standard schedule.
Question 52Question →

During routine well-child visits, developmental surveillance is a critical component of preventive care. Arrange the following communication and language milestones in the correct chronological order of their typical emergence in a healthy developing child, from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological progression of language milestones is: cooing (2 months), babbling (6 months), saying 'mama' or 'dada' specifically (12 months), combining words into two-word phrases (24 months), and telling a simple story (4 years).
Language development follows a predictable, chronological pattern. It starts with simple vowel sounds (cooing at 2 months), progresses to consonant-vowel combinations (babbling at 6 months), meaningful single words ('mama/dada' specifically at 12 months), simple word combinations (two-word phrases at 24 months), and ultimately advances to complex narrative skills (telling a story at 4 years).

Step-by-Step Solution

1
Identify the earliest infant vocalization milestone.
Cooing is the first milestone, emerging at 2 months.
Infants begin producing simple vowel sounds before they develop the motor control to articulate consonants.
2
Identify the next stage of vocal development.
Babbling with consonant-vowel sounds emerges at 6 months.
As infants gain better control over their lips and tongue, they add basic consonants to their vocalizations.
3
Determine when words are first used with specific meaning.
Saying 'mama' or 'dada' specifically to the parents occurs at 12 months.
Although non-specific repetition happens earlier (around 9 months), assigning meaning and directing the words correctly is a 12-month milestone.
4
Identify the emergence of early word combinations.
Combining words into two-word phrases occurs at 24 months.
At 2 years of age, toddlers typically experience a language explosion, linking their growing vocabulary to form basic sentences.
5
Identify the most advanced language milestone in the list.
Telling a simple story occurs at 4 years.
This stage requires advanced vocabulary, grammatical structure, and narrative understanding.

Key Concept

Chronological progression of normal language and communication milestones in pediatric development.
Estimated Time:1m 0s
Question 53Question →

A mother brings her daughter, aged 4 years and 2 months, to the pediatric clinic for a health maintenance visit. The child was diagnosed with minimal change disease one month ago and has been taking daily oral prednisone at a dose of 2 mg/kg for the past 24 days. Her vital signs are within normal limits for her age, and physical examination reveals mild facial puffiness but is otherwise unremarkable. The mother expresses concern regarding her daughter's development, noting that the child can hop on one foot and copy a cross, but is unable to skip or draw a person with more than three body parts. A review of the electronic health record shows the patient received all recommended infant and toddler immunizations up to 18 months of age, but she has not yet received any of her preschool vaccine boosters. Which of the following is the most appropriate management regarding this patient's immunizations and development?

Show answer & explanation

Answer: Provide diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines only; offer reassurance about milestones

Answer

Provide diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines only; offer reassurance about milestones
This patient requires her preschool booster vaccines but is currently significantly immunosuppressed due to high-dose systemic corticosteroid therapy (prednisone at 2 mg/kg/day for >14 days). In this state, live-attenuated vaccines (such as measles-mumps-rubella and varicella) are strictly contraindicated due to the risk of severe, disseminated vaccine-strain infection. However, inactivated vaccines (such as diphtheria-tetanus-acellular pertussis and inactivated poliovirus) are safe and should be administered on schedule. Furthermore, the child's development is entirely age-appropriate. At 4 years of age, normal milestones include hopping on one foot, copying a cross, and drawing a person with 3 body parts. Skipping, copying a triangle, and drawing a person with 6 body parts are expected at 5 years of age. Therefore, the mother should be reassured, and no developmental referral is needed.

Step-by-Step Solution

1
Evaluate the patient's immune status based on her medication regimen.
The patient is taking prednisone at 2 mg/kg/day for over 14 days, which qualifies as highly immunosuppressive corticosteroid therapy.
To determine whether she has any immune-related contraindications to her scheduled preschool vaccines.
2
Determine which preschool vaccines are safe to administer.
Inactivated vaccines (DTaP, IPV) are safe to administer, while live-attenuated vaccines (MMR, varicella) are strictly contraindicated and must be deferred until at least one month after steroid cessation.
Live vaccines can cause fatal disseminated infections in immunocompromised hosts, whereas inactivated vaccines pose no such risk.
3
Assess the patient's developmental milestones relative to her chronological age.
The child can hop and copy a cross (expected 4-year milestones) but cannot skip or draw a 6-part person (expected 5-year milestones). This is perfectly normal for a 4-year-old.
To address the mother's concern and decide if a neurodevelopmental referral is clinically indicated.

Key Concept

High-dose systemic corticosteroids (2 mg/kg/day or 20 mg/day of prednisone for 14 or more days) are a contraindication for live-attenuated vaccines, but inactivated vaccines may be safely administered. Skipping and drawing a 6-part person are 5-year milestones, not 4-year milestones.
Question 54Question →

A 12-month-old boy is brought to the clinic for a routine well-child visit. His mother reports that he pulls to a stand and cruises along furniture, but she is concerned because he is not yet walking independently. He uses a neat pincer grasp to pick up small pieces of food. He says "mama" and "dada" specifically to his parents but uses no other recognizable words. He plays peek-a-boo and waves goodbye. The boy is due for his routine 12-month immunizations, which include the live-attenuated measles-mumps-rubella (MMR) and varicella vaccines. However, his 6-year-old sister recently underwent a hematopoietic stem cell transplant for acute myeloid leukemia and is currently severely immunocompromised. The mother asks if it is safe for the boy to receive his scheduled vaccines given his sister's condition. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Reassure the mother regarding his development and administer the MMR and varicella vaccines.

Answer

Reassure the mother regarding his development and administer the MMR and varicella vaccines.
The correct action is to reassure the mother that her child's development is perfectly on track and to administer the scheduled MMR and varicella vaccines. At 12 months of age, normal milestones include cruising, using a neat pincer grasp, saying 'mama' and 'dada' specifically, and playing social games like peek-a-boo. The lack of independent walking at exactly 12 months is a normal variant and does not require a developmental referral. Regarding immunizations, the Centers for Disease Control and Prevention (CDC) strongly recommends that healthy individuals who live with immunocompromised patients receive all routine vaccinations, including live-attenuated vaccines like MMR and varicella. This 'cocooning' strategy creates a ring of immunity around the vulnerable patient, protecting them from wild-type pathogens which cause significantly more severe disease than vaccine-strain viruses. The MMR vaccine viruses are not transmitted to contacts. While the varicella vaccine virus can rarely be transmitted if the vaccinee develops a localized vesicular rash (occurring in about 5% of cases), the recommendation remains to vaccinate; the family should simply be advised to separate the infant from the sister only if such a rash appears.

Step-by-Step Solution

1
Evaluate the child's developmental milestones for a 12-month-old infant.
Gross motor (pulls to stand, cruises), fine motor (neat pincer grasp), language ('mama'/'dada' specifically), and social (peek-a-boo, waving) are all age-appropriate. Not walking independently is normal at this age.
To determine if a developmental referral is warranted.
2
Assess the contraindications for administering live-attenuated vaccines to a patient with an immunocompromised household contact.
Healthy household contacts of immunocompromised individuals should receive routine live-attenuated vaccines (MMR, Varicella, Rotavirus) to prevent wild-type infection transmission.
To determine the safest immunization plan that protects both the patient and the severely immunocompromised sibling.
3
Synthesize the findings to select the best management strategy.
Reassure the mother about the normal milestones and proceed with administering both the MMR and varicella vaccines.
This strategy provides appropriate anticipatory guidance and adheres to CDC/AAP immunization guidelines for 'cocooning' immunocompromised individuals.

Key Concept

Healthy household contacts of severely immunocompromised patients should receive all routine age-appropriate live-attenuated vaccines (including MMR and varicella) to protect the immunocompromised family member from dangerous wild-type infections. Furthermore, independent walking is a 12- to 15-month milestone, and its absence at exactly 12 months is normal.
Estimated Time:1m 30s
Question 55Question →

An 18-month-old toddler is evaluated at a primary care clinic after relocating from another state. The parents note that he has had nasal congestion and a mild cough for the past 48 hours. His temperature is 37.8°C (100.0°F), pulse is 110/min, and respirations are 24/min. Physical examination demonstrates clear rhinorrhea and a mildly erythematous posterior oropharynx. Auscultation reveals clear breath sounds bilaterally without wheezing or crackles. He is playful, runs around the examination room, scribbles on a piece of paper, and uses approximately 15 different words. Review of his medical record indicates that his last immunizations were administered at the age of 6 months. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administer all overdue age-appropriate vaccines today

Answer

Administer all overdue age-appropriate vaccines today
The correct course of action is to administer all overdue age-appropriate vaccines simultaneously. A cornerstone of pediatric preventive care is minimizing missed opportunities for immunization. According to standard guidelines, mild acute illness (e.g., upper respiratory tract infection, mild diarrhea, otitis media), with or without a low-grade fever, is a false contraindication to vaccination. Because this patient is significantly behind on his immunization schedule (last vaccinated at 6 months of age), it is crucial to update his vaccines today. Both inactivated and live-attenuated vaccines can and should be administered safely in this clinical scenario.

Step-by-Step Solution

1
Evaluate the patient's current clinical presentation to identify any true contraindications to vaccination.
The patient has a mild upper respiratory tract infection with a low-grade fever.
Moderate to severe acute illness (with or without fever) is a valid precaution for vaccination, but mild illness is a false contraindication.
2
Assess the patient's developmental milestones to rule out any underlying neurological or developmental conditions.
The patient's motor skills (running, scribbling) and language skills (15 words) are completely normal for an 18-month-old.
Accurately identifying normal development prevents unnecessary specialist referrals that could distract from required preventive care.
3
Determine the appropriate immunization strategy based on the patient's age and previous vaccine history.
The patient is overdue for multiple vaccines since his last visit was at 6 months of age. All eligible vaccines should be given simultaneously.
Catch-up vaccination should be prioritized in healthy children to prevent missed opportunities for immunization, regardless of mild concurrent illness.

Key Concept

Mild acute illness, with or without low-grade fever, is a false contraindication to vaccination; all age-appropriate vaccines (both inactivated and live-attenuated) should be administered without delay.
Estimated Time:1m 0s
Question 56Question →

A medical student is preparing a comprehensive timeline of preventive care milestones to use during a pediatric clerkship. The student aims to map out the exact age at which specific universal screening tests are first introduced for a healthy, term, asymptomatic pediatric patient with no family history of genetic or metabolic disease. According to the American Academy of Pediatrics (AAP) Bright Futures guidelines, arrange the following universal screening interventions in chronological order based on the age they should FIRST be administered, from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence of first universal screenings is: General developmental screening (9 months), Anemia screening (12 months), Autism screening (18 months), Visual acuity testing (4 years), Dyslipidemia screening (9 to 11 years), and Major depressive disorder screening (12 years).
The American Academy of Pediatrics (AAP) Bright Futures guidelines establish a highly specific timeline for universal screening in asymptomatic children. The sequence begins with general developmental screening at 9 months. At 12 months, universal screening for anemia is indicated. At 18 months, an autism-specific screening tool is introduced. By 4 years of age, children are universally screened for visual acuity using optotype charts. Later in childhood, universal dyslipidemia screening is performed once between 9 and 11 years of age. Finally, universal screening for major depressive disorder begins at 12 years of age.

Step-by-Step Solution

1
Determine the initial age for general developmental screening.
9 months of age.
AAP guidelines recommend the first standardized general developmental screening at 9 months.
2
Determine the initial age for universal anemia screening.
12 months of age.
Term infants are universally screened for iron deficiency anemia via hemoglobin/hematocrit at 12 months, corresponding with the depletion of physiological iron stores and transition to cow's milk.
3
Determine the initial age for autism spectrum disorder screening.
18 months of age.
Autism-specific screening (e.g., M-CHAT) is universally initiated at the 18-month visit.
4
Determine the initial age for visual acuity screening using optotypes.
4 years of age.
Cooperation for visual acuity charts (optotypes) is generally sufficient by age 4, marking the start of this universal screening method.
5
Determine the initial age for universal dyslipidemia screening.
9 to 11 years of age.
A baseline lipid profile is obtained universally during this prepubertal window.
6
Determine the initial age for major depressive disorder screening.
12 years of age.
Annual universal screening for depression formally begins at age 12.

Key Concept

AAP Bright Futures Periodicity Schedule for Universal Pediatric Screening
Estimated Time:1m 30s
Question 57Question →

Match each pediatric patient presenting for a routine well-child visit with the corresponding age-appropriate universal screening test recommended by the American Academy of Pediatrics.

Click a left item, then click its matching right item

Items

A 12-month-old asymptomatic boy with no significant medical or family history
An 18-month-old asymptomatic girl with typical development and growth
A 4-year-old asymptomatic boy preparing to start a preschool program
A 10-year-old asymptomatic girl with an active lifestyle
A 12-year-old asymptomatic boy attending the clinic for an annual physical examination

Matches

Show answer & explanation

Answer

The 12-month-old matches with hemoglobin measurement. The 18-month-old matches with the autism screening tool. The 4-year-old matches with objective visual acuity testing. The 10-year-old matches with a lipid profile. The 12-year-old matches with the standardized depression screening questionnaire.
The correct matches align with the American Academy of Pediatrics (AAP) periodicity schedule for universal screening. At 12 months, infants are universally screened for anemia. At 18 months, toddlers receive their first formal autism spectrum disorder screening. At 4 years, children are cognitively mature enough for objective visual acuity testing using a chart. Between ages 9 and 11 (e.g., 10 years old), children undergo universal dyslipidemia screening. At 12 years, universal depression screening begins for adolescents.

Step-by-Step Solution

1
Identify the purpose of the clinical encounter.
Each scenario describes a routine health maintenance examination for an asymptomatic pediatric patient at a specific age milestone.
This establishes that universal screening guidelines, rather than targeted risk-based guidelines, apply.
2
Recall the American Academy of Pediatrics (AAP) Bright Futures periodicity schedule.
Identify the specific universal screening tests uniquely introduced or emphasized at 12 months, 18 months, 4 years, 10 years, and 12 years.
Matching age milestones to screening protocols is a core competency in pediatric preventive care.
3
Pair each patient profile with the correct intervention.
12 months to anemia screening, 18 months to autism screening, 4 years to vision testing, 10 years to lipid screening, and 12 years to depression screening.
This completes the matching requirement based on established pediatric guidelines.

Key Concept

Universal Pediatric Screening Guidelines (AAP Bright Futures periodicity schedule)
Question 58Question →

A pediatric clinic is reviewing its protocols for routine health maintenance and immunization delivery. The clinical educator asks the medical students to outline the chronological progression of vaccinations. Arrange the following immunization milestones in chronological order based on the age at which they are routinely indicated for a healthy, full-term child in the United States, starting from the earliest intervention.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence begins with the standalone Hepatitis B vaccine at birth, followed by the initial DTaP/IPV/Hib/PCV/rotavirus series at 2 months, the introduction of MMR and varicella at 12 months, the preschool boosters at 4 to 6 years, and finally the adolescent Tdap/MenACWY/HPV platform at 11 to 12 years.
The sequence directly follows the CDC immunization schedule. The Hepatitis B vaccine is given at birth. The core inactivated infant series (plus oral rotavirus) begins at 2 months. Subcutaneous live vaccines (MMR, varicella) are withheld until 12 months to avoid maternal antibody interference. A major booster combination (DTaP, IPV, MMR, varicella) is given at 4 to 6 years before school entry. Finally, the adolescent platform (Tdap, MenACWY, HPV) is administered at 11 to 12 years.

Step-by-Step Solution

1
Identify the recommended age for the standalone Hepatitis B vaccination.
Birth (within 24 hours).
This is the only vaccine routinely administered in the newborn nursery to prevent vertical transmission.
2
Identify the recommended age for the initial DTaP, IPV, Hib, pneumococcal conjugate, and rotavirus series.
2 months of age.
The primary series for these core infant vaccines universally begins at the 2-month well-child visit.
3
Identify the recommended age for the first doses of subcutaneous live-attenuated vaccines (MMR and varicella).
12 to 15 months of age.
Administration is delayed until at least 12 months of age to prevent interference from passive maternal antibodies.
4
Identify the recommended age for the preschool boosters of DTaP, IPV, MMR, and varicella.
4 to 6 years of age.
These boosters are required to maintain immunity prior to the increased exposure risk of entering school.
5
Identify the recommended age for the adolescent vaccine platform (Tdap, MenACWY, HPV).
11 to 12 years of age.
This cluster of vaccines is specifically designed to provide protection against diseases with increased risk during adolescence and adulthood.
6
Sequence the interventions chronologically.
Birth -> 2 months -> 12-15 months -> 4-6 years -> 11-12 years.
This outlines the standard trajectory of the pediatric immunization schedule.

Key Concept

The CDC Recommended Child and Adolescent Immunization Schedule outlines a highly specific, age-based timeline for the introduction and boosting of vaccines to maximize immunogenicity and prevent disease outbreaks.
Question 59Question →

A couple brings their 8-month-old son to the pediatric clinic for a pre-travel consultation. They are scheduled to relocate temporarily to a rural region in Sub-Saharan Africa in two weeks. This region currently has high endemic rates of both measles and hepatitis A. The boy was born prematurely at 32 weeks gestation following an uncomplicated pregnancy and neonatal course. His routine immunizations are up to date according to his chronological age. The parents report that he has had mild nasal congestion and a clear nasal discharge for the past two days. On examination, his temperature is 37.6°C (99.7°F). He is playful, well-appearing, and in no respiratory distress. Neurologic examination reveals that he is able to roll from back to front and sits leaning forward on his hands, but he falls over when his hands are removed. Which of the following is the most appropriate management plan for this patient today?

Show answer & explanation

Answer: Administer measles-mumps-rubella (MMR) and hepatitis A vaccines, and advise that both will need to be re-administered starting at age 12 months

Answer

Administer measles-mumps-rubella (MMR) and hepatitis A vaccines, and advise that both will need to be re-administered starting at age 12 months
The most appropriate management is to administer both the MMR and hepatitis A vaccines today, and advise the parents that these doses will need to be repeated starting at 12 months of age. According to current pediatric immunization guidelines, infants aged 6 to 11 months who are traveling internationally to highly endemic areas should receive one dose of the MMR vaccine and one dose of the hepatitis A vaccine prior to departure. However, because circulating maternal antibodies can blunt the infant's immune response, doses administered before 12 months of age do not provide reliable long-term immunity and do not count toward the routine pediatric immunization series. Furthermore, the infant's mild upper respiratory infection is a false contraindication to vaccination, and his developmental milestones (rolling, tripod sitting) are perfectly normal for his corrected gestational age of 6 months.

Step-by-Step Solution

1
Evaluate the patient's travel risk and age-based vaccine indications.
The patient is 8 months old and traveling to a highly endemic area for measles and hepatitis A.
Infants aged 6 to 11 months are at high risk for severe complications from measles and hepatitis A during international travel, prompting specific early vaccination protocols.
2
Determine if the early vaccine doses will count toward the standard pediatric series.
Doses given before 12 months of age do not count toward the routine series.
Circulating maternal IgG antibodies in infants under 12 months can neutralize the vaccine antigens, preventing the formation of a robust, long-lasting memory B-cell response.
3
Assess the patient's developmental milestones based on his prematurity.
Chronological age is 8 months; corrected age is 6 months (born at 32 weeks). Tripod sitting is a normal 6-month milestone.
Premature infants are assessed for developmental milestones based on their corrected gestational age to avoid false diagnoses of developmental delay.
4
Assess the patient's current mild illness as a potential vaccine contraindication.
The patient has a mild viral upper respiratory infection, which is a false contraindication.
Mild acute illnesses, with or without low-grade fever, do not significantly impair the immune response to vaccines or increase the risk of adverse vaccine reactions.

Key Concept

Immunization management for international travel in premature infants
Estimated Time:2m 0s
Question 60Question →

A 4-year-old boy is brought to the pediatric clinic by his father for a routine well-child visit. His father reports that the boy is active, eats a balanced diet, and attends preschool without issues. The boy's 7-year-old sister was recently diagnosed with acute lymphoblastic leukemia and is currently undergoing induction chemotherapy. The father expresses concern that the vaccines scheduled for the 4-year-old today might pose an infection risk to the immunocompromised sister. The boy is up to date on all prior immunizations. Vital signs are within normal limits. Physical examination reveals an energetic, well-nourished child with no abnormalities. Which of the following is the most appropriate next step in management regarding this patient's immunizations today?

Show answer & explanation

Answer: Administer all routine age-appropriate vaccines, including the measles-mumps-rubella and varicella vaccines

Answer

The correct approach is to administer all routine age-appropriate vaccines, including the measles-mumps-rubella (MMR) and varicella vaccines.
The most appropriate management is to administer all routine age-appropriate vaccines, including the live-attenuated measles-mumps-rubella (MMR) and varicella vaccines. Establishing a 'cocoon' of immunity around an immunocompromised patient by fully vaccinating their close contacts is a critical preventive strategy. The MMR vaccine virus is not transmissible to contacts. The varicella vaccine virus can theoretically be transmitted if the vaccinated individual develops a vesicular rash (which occurs in roughly 5% of recipients); however, the overall benefit of preventing wild-type varicella in the household easily outweighs this risk. If a vaccine-related rash does develop, the sibling should simply avoid contact with the vaccinee until the lesions crust over. The only live vaccine generally contraindicated for close contacts of severely immunocompromised individuals (specifically those requiring a protected environment, such as recent hematopoietic stem cell transplant recipients) is the live-attenuated influenza vaccine (LAIV).

Step-by-Step Solution

1
Identify the patient's demographic and clinical situation.
A healthy 4-year-old child presenting for routine immunizations, who lives with a severely immunocompromised sibling.
Household contact status heavily influences the risk-benefit analysis of live-attenuated vaccine administration.
2
Determine the routine vaccines indicated for a 4-year-old child.
The indicated vaccines are DTaP, IPV, MMR, and Varicella.
Establishing the baseline immunization requirement is necessary before assessing for contraindications.
3
Evaluate contraindications regarding live-attenuated vaccines in contacts of immunocompromised patients.
MMR and Varicella vaccines are strongly recommended for household contacts. The MMR vaccine virus is not transmitted, and the Varicella vaccine poses a transmission risk only if a vesicular rash develops, which is rare and easily manageable.
Protecting the healthy sibling establishes a protective 'cocoon' around the immunocompromised patient, preventing the introduction of dangerous wild-type infections into the home.
4
Select the management plan that aligns with current immunization guidelines.
Administer all routine vaccines today without alteration.
The benefits of herd immunity vastly outweigh the theoretical risks of vaccine virus transmission.

Key Concept

Healthy household contacts of immunocompromised individuals should receive all routine age-appropriate immunizations, including live-attenuated vaccines like MMR and Varicella, to establish herd immunity.
PreviousPage 3 / 6Next
Preventive Care and Immunizations Practice Questions — USMLE Step 2 CK — Page 3 | Examkin